Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary vaccine delivery.

Dongmei Lu1, Anthony J Hickey

  • 1Division of Molecular Pharmaceutics, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ludm@email.unc.edu

Expert Review of Vaccines
|April 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secondary B-Cell Acute Lymphoblastic Leukemia Following Multiple Myeloma Treatment.

Clinical laboratory·2026
Same author

Intermittent Hypoxemia in Preterm Infants: Glial Fibrillary Acidic Protein as a Potential Brain Injury Biomarker.

Respiratory physiology & neurobiology·2026
Same author

Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial.

JAMA·2026
Same author

Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approach.

Frontiers in tuberculosis·2026
Same author

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.

Lancet (London, England)·2026
Same author

Effect of biofilm formation on the antimicrobial activity of tigecycline against <i>Mycobacterium abscessus</i> in the hollow fiber infection model.

Frontiers in microbiology·2026
Same journal

Projected health and economic impact of PCV20 vaccination in UK children: a dynamic transmission model.

Expert review of vaccines·2026
Same journal

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Whole cell and acellular pertussis vaccines - rethinking the evidence.

Expert review of vaccines·2026
Same journal

Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic.

Expert review of vaccines·2026
Same journal

Narrative shielding and prebunking: a synergistic strategy against vaccine hesitancy in pediatrics.

Expert review of vaccines·2026
See all related articles

Pulmonary vaccine delivery using aerosol technology offers a safe, low-cost method for immunization. This approach enhances vaccine stability and antigenicity, benefiting public health vaccination campaigns.

Area of Science:

  • Pulmonary drug delivery
  • Vaccine technology
  • Immunization strategies

Background:

  • Traditional vaccine administration methods face challenges in stability and patient compliance.
  • Pulmonary delivery presents a noninvasive alternative for vaccine administration.

Purpose of the Study:

  • To review advancements in pulmonary vaccine delivery systems.
  • To explore the potential of aerosol-generation technology for immunization.
  • To discuss formulation components and their impact on pulmonary vaccine efficacy.

Main Methods:

  • Review of current literature on aerosol-generation systems for vaccine delivery.
  • Analysis of pharmaceutical formulations, including adjuvants, surfactants, and particulate systems.
  • Discussion of aerosol dispersion and its implications for pulmonary immunization.

Related Experiment Videos

Main Results:

  • Aerosol-generation systems show promise for improving vaccine stability and antigenicity.
  • Optimized formulations can enhance the effectiveness of pulmonary vaccine delivery.
  • Pulmonary delivery offers advantages in terms of safety and cost-effectiveness.

Conclusions:

  • Pulmonary vaccine delivery via aerosolization is a viable and beneficial strategy for public health.
  • Further development in aerosol technology and formulation can optimize vaccine efficacy.
  • Noninvasive pulmonary immunization holds significant potential for widespread vaccination campaigns.